2-Macroglobulin Reveals Mimicry of Eukaryotic Innate Immunity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Downloaded from NCBI
bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Proteolysis and neurogenesis modulated by LNR domain proteins explosion 2 support male differentiation in the crustacean Oithona nana 3 Kevin Sugier1, Romuald Laso-Jadart1, Soheib Kerbache1, Jos Kafer4, Majda Arif1, Laurie Bertrand2, Karine 4 Labadie2, Nathalie Martins2, Celine Orvain2, Emmanuelle Petit2, Julie Poulain1, Patrick Wincker1, Jean-Louis 5 Jamet3, Adriana Alberti2 and Mohammed-Amin Madoui1 6 1. Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Univ Evry, Université 7 Paris-Saclay, Evry, France 8 2. Commissariat à l'Energie Atomique (CEA), Institut François Jacob, Genoscope, Evry, France 9 3. Université de Toulon, Aix-Marseille Université, CNRS/INSU/IRD, Mediterranean Institute of 10 Oceanography MIO UMR 7294, CS 60584, 83041 Toulon cedex 9, France 11 4. Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, CNRS UMR 5558, France 12 bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 13 Abstract 14 Copepods are the most numerous animals and play an essential role in the marine trophic web 15 and biogeochemical cycles. The genus Oithona is described as having the highest numerical 16 density, as the most cosmopolite copepod and iteroparous. The Oithona male paradox obliges 17 it to alternate feeding (immobile) and mating (mobile) phases. -
Human Placenta Exosomes: Biogenesis, Isolation, Composition, and Prospects for Use in Diagnostics
International Journal of Molecular Sciences Review Human Placenta Exosomes: Biogenesis, Isolation, Composition, and Prospects for Use in Diagnostics Evgeniya E. Burkova 1,* , Sergey E. Sedykh 1,2 and Georgy A. Nevinsky 1,2 1 SB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia; [email protected] (S.E.S.); [email protected] (G.A.N.) 2 Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia * Correspondence: [email protected]; Tel.: +7-(383)-363-51-27 Abstract: Exosomes are 40–100 nm nanovesicles participating in intercellular communication and transferring various bioactive proteins, mRNAs, miRNAs, and lipids. During pregnancy, the placenta releases exosomes into the maternal circulation. Placental exosomes are detected in the maternal blood even in the first trimester of pregnancy and their numbers increase significantly by the end of pregnancy. Exosomes are necessary for the normal functioning of the placenta and fetal development. Effects of exosomes on target cells depend not only on their concentration but also on their intrinsic components. The biochemical composition of the placental exosomes may cause various complications of pregnancy. Some studies relate the changes in the composition of nanovesicles to placental dysfunction. Isolation of placental exosomes from the blood of pregnant women and the study of protein, lipid, and nucleic composition can lead to the development of methods for early diagnosis of pregnancy pathologies. This review describes the biogenesis of exosomes, methods Citation: Burkova, E.E.; Sedykh, S.E.; of their isolation, analyzes their biochemical composition, and considers the prospects for using Nevinsky, G.A. Human Placenta exosomes to diagnose pregnancy pathologies. -
Plant Protease Inhibitors: a Defense Strategy in Plants
Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1. -
Functional Characterization of Extracellular Protease Inhibitors of Phytophthora Infestans
FUNCTIONAL CHARACTERIZATION OF EXTRACELLULAR PROTEASE INHIBITORS OF PHYTOPHTHORA INFESTANS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Miaoying Tian, M.S. * * * * * The Ohio State University 2005 Dissertation Committee: Dr. Sophien Kamoun, Adviser Dr. Terrence L. Graham Approved by Dr. Saskia A. Hogenhout Dr. Margaret G. Redinbaugh Adviser Dr. Guo-Liang Wang Graduate Program in Plant Pathology ABSTRACT The oomycetes form one of several lineages within the eukaryotes that independently evolved a parasitic lifestyle and are thought to have developed unique mechanisms of pathogenicity. The devastating oomycete plant pathogen Phytophthora infestans causes late blight, a ravaging disease of potato and tomato. Little is known about processes associated with P. infestans pathogenesis, particularly the suppression of host defense responses. We used data mining of P. infestans sequence databases to identify 18 extracellular protease inhibitors belonging to two major structural classes: (i) Kazal-like serine protease inhibitors (EPI1 to EPI14) and (ii) cystatin-like cysteine protease inhibitors (EPIC1 to EPIC4). A variety of molecular, biochemical and bioinformatic approaches were employed to functionally characterize these genes and investigate their roles in pathogen virulence. The 14 EPI proteins form a diverse family and appear to have evolved by domain shuffling, gene duplication, and diversifying selection to target a diverse array of serine proteases. Recombinant EPI1 and EPI10 proteins inhibited subtilisin A among major serine proteases, and inhibited and interacted with tomato P69B subtilase, a pathogenesis-related protein belonging to PR7 class. The recombinant cystatin-like cysteine protease inhibitor EPIC2B interacted with a novel tomato papain-like extracellular cysteine protease PIP1 with an implicated role in plant defense. -
Detailed Structure and Pathophysiological Roles of the Iga-Albumin Complex in Multiple Myeloma
International Journal of Molecular Sciences Article Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma Yuki Kawata 1, Hisashi Hirano 1, Ren Takahashi 1, Yukari Miyano 1, Ayuko Kimura 1, Natsumi Sato 1, Yukio Morita 2, Hirokazu Kimura 1,* and Kiyotaka Fujita 1 1 Department of Health Sciences, Gunma Paz University Graduate School of Health Sciences, 1-7-1, Tonyamachi, Takasaki-shi, Gunma 370-0006, Japan; [email protected] (Y.K.); [email protected] (H.H.); [email protected] (R.T.); [email protected] (Y.M.); [email protected] (A.K.); [email protected] (N.S.); [email protected] (K.F.) 2 Laboratory of Public Health II, Azabu University School of Veterinary Medicine, 1-17-71, Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-27-365-3366; Fax: +81-27-388-0386 Abstract: Immunoglobulin A (IgA)-albumin complexes may be associated with pathophysiology of multiple myeloma, although the etiology is not clear. Detailed structural analyses of these protein– protein complexes may contribute to our understanding of the pathophysiology of this disease. We analyzed the structure of the IgA-albumin complex using various electrophoresis, mass spectrom- etry, and in silico techniques. The data based on the electrophoresis and mass spectrometry showed that IgA in the sera of patients was dimeric, linked via the J chain. Only dimeric IgA can bind to albumin molecules leading to IgA-albumin complexes, although both monomeric and dimeric forms of IgA were present in the sera. -
Decision Summary
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: k081249 B. Purpose for Submission: New analyte, controls, and calibrator C. Measurand: Alpha 2 macroglobulin D. Type of Test: Quantitative, Nephelometric E. Applicant: Dade Behring, Inc. F. Proprietary and Established Names: Dimension Vista System A2mac Flex Reagent Cartridge, Dimension Vista System Protein 1 Calibrator, Dimension Vista System. G. Regulatory Information: Regulation Section Classification Product Code Panel 21 CFR 866.5620, Alpha- Class II Alpha-2-Macroglobulin, 82 Immunology 2-macroglobulin Antigen, Antiserum, (IM) immunological test Control (DEB) system. 21 CFR 862.1660, Quality Class I Multi-Analyte Controls, 75 Clinical control material (assayed All Kinds (Assayed) Chemistry and unassayed). (JJY) (CH) 21 CFR 862.1150, Class II Calibrator, Multi- 75 Clinical Calibrator. Analyte Mixture (JIX) Chemistry (CH) H. Intended Use: 1. Intended use(s): Dimension Vista® System A2MAC Flex® Reagent Cartridge The A2MAC assay is an in vitro diagnostic test for the quantitative measurement of alpha2-macroglobulin in human serum and heparinized and EDTA plasma on the Dimension Vista® Systems. Measurements of a2-macroglobulin aid in the diagnosis of blood clotting or blood lysis disorders. Dimension Vista® Protein 1 Calibrator Dimension Vista® Protein 1 Calibrator is an in vitro diagnostic product for the calibration of the Dimension Vista® System for: α1-Acid Glycoprotein (A1AG), α1-Antitrypsin(A1AT), α2-Macroglobulin (A2MAC), β2-Microglobulin (B2MIC), C3 Complement (C3), C4 Complement (C4), Ceruloplasmin(CER), Haptoglobin (HAPT), Hemopexin (HPX), Homocysteine (HCYS), Immunoglobulin A (IGA), Immunoglobulin E (IGE), Immunoglobulin G (IGG, IGG-C*), Immunoglobulin G Subclass 1, (IGG1), Immunoglobulin G Subclass 2 (IGG2), Immunoglobulin G 1 Subclass 3 (IGG3), Immunoglobulin Subclass 4 (IGG4), Immunoglobulin M (IGM), Prealbumin (PREALB), Retinol Binding Protein (RBP), soluble Transferrin Receptor (sTFR) and Transferring (TRF). -
904 Genetics of Human Complement Component C4
[Frontiers in Bioscience 6, d904-913, August 1, 2001] GENETICS OF HUMAN COMPLEMENT COMPONENT C4 AND EVOLUTION THE CENTRAL MHC O. Patricia Martinez,1 Natalie Longman-Jacobsen,1 Richard Davies,1 Erwin K. Chung,2 Yan Yang,2 Silvana Gaudieri,1 Roger L. Dawkins,1 and C. Yung Yu2 1 Centre for Molecular Immunology and Instrumentation, University of Western Australia, PO Box 5100, Canning Vale WA 6155, Australia, 2 Children’s Research Institute, Columbus, Ohio, and Department of Pediatrics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, 700 Children’s Drive, Columbus Ohio 43205 TABLE OF CONTENTS 1. Abstract 2. The Genetic Diversity and the Nomenclature of Human C4A and C4B 3. Evolution of the MHC-Complement Proteins and the Central MHC 4. Paralogy Mapping Could Help Identify Candidate Genes for MHC – Associated Diseases: Prospects for the Central MHC 5. Acknowledgments 6. References 1. ABSTRACT 2. THE GENETIC DIVERSITY AND THE NOMENCLATURE OF HUMAN C4A AND C4B The two classes of human complement The human complement component C4 is one of component C4 proteins C4A and C4B manifest differential the most complex and polymorphic molecules. The chemical reactivities and binding affinities towards target activated product of C4, C4b, is a non-catalytic subunit C3 surfaces and complement receptor CR1. There are multiple, and C5 convertase in the classical and lectin pathways polymorphic allotypes of C4A and C4B proteins. A (reviewed in refs. 1, 2). Downstream of C4, the complex multiplication pattern of C4A and C4B genes with complement pathway includes the generation of variations in gene size, gene dosage and flanking genes anaphylatoxins C3a and C5a, and the assembly of the exists in the population. -
(12) United States Patent (10) Patent No.: US 6,342,350 B1 Tanzi Et Al
USOO6342350B1 (12) United States Patent (10) Patent No.: US 6,342,350 B1 Tanzi et al. (45) Date of Patent: Jan. 29, 2002 (54) ALPHA-2-MACROGLOBULIN DIAGNOSTIC with Chinese late onset Alzheimer's Disease,” Neuroscience TEST Letters 269:173–177 (1999). Dodel, R.C., et al., “C-2 Macroglobulin and the Risk of (75) Inventors: Rudolph E. Tanzi, Hull; Bradley T. Alzheimer's Disease,” Neurology 54:438-442 (2000). Hyman, Swampscott; George W. Dow, D.J., et al., “C-2 Macroglobulin Polymorphism and Rebeck, Somerville; Deborah L. Alzheimer Disease risk in the UK,” Nature Genetics Blacker, Newton, all of MA (US) 22:16–17 (May 1999). (73) Assignee: The General Hospital Corporation, Du, Y., et al., “c-Macroglobulin Attenuates B-Amyloid Boston, MA (US) Peptide 1-40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical Neurons,” J. of Neurochem. (*) Notice: Subject to any disclaimer, the term of this 70: 1182–1188 (1998). patent is extended or adjusted under 35 Gauderman, W.J., et al., “Family-Based Association Stud U.S.C. 154(b) by 0 days. ies.” Monogr: Natl. Canc. Inst. 26:31-37 (1999). Hampe, J., et al., “Genes for Polygenic Disorders: Consid (21) Appl. No.: 09/148,503 erations for Study Design in the Complex Trait of Inflam (22) Filed: Sep. 4, 1998 matory Bowel Disease,” Hum. Hered 50:91-101 (Mar.-Apr. 2000). Related U.S. Application Data Horvath, S., and Laird, N.M., “A Discordant-Sibship Test (60) Provisional application No. 60/093,297, filed on Jul. 17, for Disequilibrium and Linkage: No Need for Parental 1998, and provisional application No. -
Insights Into the Role of Tick Salivary Protease Inhibitors During Ectoparasite–Host Crosstalk
International Journal of Molecular Sciences Review Insights into the Role of Tick Salivary Protease Inhibitors during Ectoparasite–Host Crosstalk Mohamed Amine Jmel 1,† , Hajer Aounallah 2,3,† , Chaima Bensaoud 1, Imen Mekki 1,4, JindˇrichChmelaˇr 4, Fernanda Faria 3 , Youmna M’ghirbi 2 and Michalis Kotsyfakis 1,* 1 Laboratory of Genomics and Proteomics of Disease Vectors, Biology Centre CAS, Institute of Parasitology, Branišovská 1160/31, 37005 Ceskˇ é Budˇejovice,Czech Republic; [email protected] (M.A.J.); [email protected] (C.B.); [email protected] (I.M.) 2 Institut Pasteur de Tunis, Université de Tunis El Manar, LR19IPTX, Service d’Entomologie Médicale, Tunis 1002, Tunisia; [email protected] (H.A.); [email protected] (Y.M.) 3 Innovation and Development Laboratory, Innovation and Development Center, Instituto Butantan, São Paulo 05503-900, Brazil; [email protected] 4 Faculty of Science, University of South Bohemia in Ceskˇ é Budˇejovice, 37005 Ceskˇ é Budˇejovice, Czech Republic; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Protease inhibitors (PIs) are ubiquitous regulatory proteins present in all kingdoms. They play crucial tasks in controlling biological processes directed by proteases which, if not tightly regulated, can damage the host organism. PIs can be classified according to their targeted proteases or their mechanism of action. The functions of many PIs have now been characterized and are showing clinical relevance for the treatment of human diseases such as arthritis, hepatitis, cancer, AIDS, and cardiovascular diseases, amongst others. Other PIs have potential use in agriculture as insecticides, anti-fungal, and antibacterial agents. -
Proceedings of the Fifty-Eighth Annual Meeting of the American Society for Clinical Investigation, Inc., Held in Atlantic City, N.J., May 2, 1966: Abstracts
Proceedings of the Fifty-Eighth Annual Meeting of the American Society for Clinical Investigation, Inc., Held in Atlantic City, N.J., May 2, 1966: Abstracts J Clin Invest. 1966;45(6):980-1037. https://doi.org/10.1172/JCI105414. Research Article Find the latest version: https://jci.me/105414/pdf ABSTRACTS Comparison of Effects of Alpha Adrenergic Blockade luminescence. Inhibition of ATPase activities by ouabain, on Resistance and Capacitance Vessels. FRANCOIS parachloromercuribenzoate (PCMB), and parachloro- M. ABBOUD * AND JOHN W. ECKSTEIN,* Iowa City, mercuribenzenesulfonate (PCMBS) was studied. ¶1 Mem- Iowa. brane ATPase of osmotically prepared platelet "ghosts" A foreleg of each of 20 dogs was perfused with blood is composed of Na+-K+-Mg++-dependent ATPase (15 to at a constant rate through the brachial artery. The 30%) and Mg++-activated ATPase (60 to 85%o). Ouabain nerves of the brachial plexus were transected, and an (10' M), which inhibits the Na+-K--dependent ATPase electrode was applied to their distal ends. Pressures were activity and produces a resultant loss of cellular K+, gain recorded simultaneously from the brachial artery and of Na+, and cell swelling, does not inhibit either ADP cephalic vein and from a small artery and small vein in aggregation or clot retraction. ¶f PCMB, an organic the paw. Pressor responses to injections of nor- mercurial compound that diffuses into cells, totally inacti- epinephrine (1, 2, and 4 /.tg) into the brachial artery and vates both ATPase activities in the ghost preparations to nerve stimulation (3, 6, and 12 cps) were measured and in the intact platelet. -
Supplementary Table S1 List of Proteins Identified with LC-MS/MS in the Exudates of Ustilaginoidea Virens Mol
Supplementary Table S1 List of proteins identified with LC-MS/MS in the exudates of Ustilaginoidea virens Mol. weight NO a Protein IDs b Protein names c Score d Cov f MS/MS Peptide sequence g [kDa] e Succinate dehydrogenase [ubiquinone] 1 KDB17818.1 6.282 30.486 4.1 TGPMILDALVR iron-sulfur subunit, mitochondrial 2 KDB18023.1 3-ketoacyl-CoA thiolase, peroxisomal 6.2998 43.626 2.1 ALDLAGISR 3 KDB12646.1 ATP phosphoribosyltransferase 25.709 34.047 17.6 AIDTVVQSTAVLVQSR EIALVMDELSR SSTNTDMVDLIASR VGASDILVLDIHNTR 4 KDB11684.1 Bifunctional purine biosynthetic protein ADE1 22.54 86.534 4.5 GLAHITGGGLIENVPR SLLPVLGEIK TVGESLLTPTR 5 KDB16707.1 Proteasomal ubiquitin receptor ADRM1 12.204 42.367 4.3 GSGSGGAGPDATGGDVR 6 KDB15928.1 Cytochrome b2, mitochondrial 34.9 58.379 9.4 EFDPVHPSDTLR GVQTVEDVLR MLTGADVAQHSDAK SGIEVLAETMPVLR 7 KDB12275.1 Aspartate 1-decarboxylase 11.724 112.62 3.6 GLILTLSEIPEASK TAAIAGLGSGNIIGIPVDNAAR 8 KDB15972.1 Glucosidase 2 subunit beta 7.3902 64.984 3.2 IDPLSPQQLLPASGLAPGR AAGLALGALDDRPLDGR AIPIEVLPLAAPDVLAR AVDDHLLPSYR GGGACLLQEK 9 KDB15004.1 Ribose-5-phosphate isomerase 70.089 32.491 32.6 GPAFHAR KLIAVADSR LIAVADSR MTFFPTGSQSK YVGIGSGSTVVHVVDAIASK 10 KDB18474.1 D-arabinitol dehydrogenase 1 19.425 25.025 19.2 ENPEAQFDQLKK ILEDAIHYVR NLNWVDATLLEPASCACHGLEK 11 KDB18473.1 D-arabinitol dehydrogenase 1 11.481 10.294 36.6 FPLIPGHETVGVIAAVGK VAADNSELCNECFYCR 12 KDB15780.1 Cyanovirin-N homolog 85.42 11.188 31.7 QVINLDER TASNVQLQGSQLTAELATLSGEPR GAATAAHEAYK IELELEK KEEGDSTEKPAEETK LGGELTVDER NATDVAQTDLTPTHPIR 13 KDB14501.1 14-3-3 -
Reproductionresearch
REPRODUCTIONRESEARCH SPINK3 modulates mouse sperm physiology through the reduction of nitric oxide level independently of its trypsin inhibitory activity L Zalazar, T E Saez Lancellotti1, M Clementi1, C Lombardo, L Lamattina, R De Castro, M W Forne´s1 and A Cesari Instituto de Investigaciones Biolo´gicas (IIB), Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Mar del Plata, CCT–Mar del Plata, CONICET, Funes 3250, 4th Floor, Mar del Plata 7600, Argentina and 1Laboratorio de Investigaciones Androlo´gicas de Mendoza (LIAM, IHEM–CONICET), Facultad de Ciencias Me´dicas, Universidad Nacional de Cuyo, CCT–Mendoza, CONICET, Mendoza, Argentina Correspondence should be addressed to A Cesari; Email: [email protected] M W Forne´s and A Cesari contributed equally to this work Abstract Serine protease inhibitor Kazal-type (SPINK3)/P12/PSTI-II is a small secretory protein from mouse seminal vesicle which contains a C KAZAL domain and shows calcium (Ca2 )-transport inhibitory (caltrin) activity. This molecule was obtained as a recombinant protein and its effect on capacitated sperm cells was examined. SPINK3 inhibited trypsin activity in vitro while the fusion protein GST-SPINK3 had no effect on this enzyme activity. The inactive GST-SPINK3 significantly reduced the percentage of spermatozoa positively stained for nitric oxide (NO) with the specific probe DAF-FM DA and NO concentration measured by Griess method in capacitated mouse sperm; C the same effect was observed when sperm were capacitated under low Ca2 concentration, using either intracellular (BAPTA-AM) or C extracellular Ca2 (EDTA) chelators. The percentage of sperm showing spontaneous and progesterone-induced acrosomal reaction was significantly lower in the presence of GST-SPINK3 compared to untreated capacitated spermatozoa.